These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16036303)

  • 1. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
    Muvaffak A; Gurhan I; Gunduz U; Hasirci N
    J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatin-methotrexate conjugate microspheres as a potential drug delivery system.
    Pica K; Tchao R; Ofner CM
    J Pharm Sci; 2006 Sep; 95(9):1896-908. PubMed ID: 16850436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged cytotoxic effect of colchicine released from biodegradable microspheres.
    Muvaffak A; Gurhan I; Hasirci N
    J Biomed Mater Res B Appl Biomater; 2004 Nov; 71(2):295-304. PubMed ID: 15386399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release systems for proteins based on gelatin microspheres.
    Rao JK; Ramesh DV; Rao KP
    J Biomater Sci Polym Ed; 1994; 6(5):391-8. PubMed ID: 7841146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levofloxacin and pefloxacin on humoral immune response elicited by bovine serum albumin docked in gelatin microparticles and nanoparticles.
    Madan J; Kaushik D; Sardana S; Ali A; Sudhakaran Sudheesh M; Shankar Pandey R
    Pharmazie; 2010 Apr; 65(4):284-9. PubMed ID: 20432626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system.
    Zhang X; Chen F; Ni J
    Drug Deliv; 2009 Jul; 16(5):280-8. PubMed ID: 19538010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats.
    Yoshikawa Y; Komuta Y; Nishihara T; Itoh Y; Yoshikawa H; Takada K
    J Drug Target; 1999; 6(6):449-61. PubMed ID: 10937290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
    Hao X; Cheng G; Zou M; Sun J; Cui F
    Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer.
    Hussain M; Beale G; Hughes M; Akhtar S
    Int J Pharm; 2002 Mar; 234(1-2):129-38. PubMed ID: 11839444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil monodispersed chitosan microspheres: Microfluidic chip fabrication with crosslinking, characterization, drug release and anticancer activity.
    He T; Wang W; Chen B; Wang J; Liang Q; Chen B
    Carbohydr Polym; 2020 May; 236():116094. PubMed ID: 32172896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
    Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheres.
    Muvaffak A; Gürhan I; Hasirci N
    J Microencapsul; 2004 May; 21(3):293-306. PubMed ID: 15204596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and in vitro evaluation of gelatin microspheres containing an antitumour tetra-amidine.
    Nastruzzi C; Pastesini C; Cortesi R; Esposito E; Gambari R; Menegatti E
    J Microencapsul; 1994; 11(3):249-60. PubMed ID: 8064549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
    Han JH; Oh YK; Kim DS; Kim CK
    Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatin microspheres and sponges for delivery of macromolecules.
    Ulubayram K; Eroglu I; Hasirci N
    J Biomater Appl; 2002 Jan; 16(3):227-41. PubMed ID: 11939457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monodisperse gelatin microspheres as a drug delivery vehicle: release profile and effect of crosslinking density.
    Choy YB; Cheng F; Choi H; Kim KK
    Macromol Biosci; 2008 Aug; 8(8):758-65. PubMed ID: 18446808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.
    Chandy T; Das GS; Rao GH
    J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-fluorouracil loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro release.
    Kaushik D; Sardana S; Mishra DN
    Yao Xue Xue Bao; 2009 Nov; 44(11):1278-84. PubMed ID: 21351727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres.
    Narayani R; Rao KP
    J Microencapsul; 1994; 11(1):69-77. PubMed ID: 8138876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.